Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

ATRA $42.41 3.3900 +8.69%
OGXI $3.14 0.2200 +7.53%
CCXI $6.53 0.3400 +5.49%
TKAI $12.71 0.6600 +5.48%
DRNA $11.14 0.5400 +5.09%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ARIA $7.37 -1.7300 -19.02%
APRI $1.62 -0.1579 -8.87%
SPPI $6.74 -0.2800 -3.99%
CPXX $2.15 -0.0801 -3.59%
BDSI $6.23 -0.2100 -3.26%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | Next > | Last >>

Advance in Photodynamic Therapy Offers New Approach to Ovarian Cancer

(OSU) Aug 13, 2015 - Researchers at Oregon State University have made a significant advance in the use of photodynamic therapy to combat ovarian cancer in laboratory animals, using a combination of techniques that achieved complete cancer cell elimination with no regrowth of tumors.
read press release 

A Better Way to Personalize Bladder Cancer Treatments

(UC Davis) Aug 13, 2015 - Researchers at UC Davis, in collaboration with colleagues at Jackson Laboratory, have developed a new way to personalize treatments for aggressive bladder cancer.
read press release 

Testing for More Breast Cancer Genes Offers Useful Information

(Reuters) Aug 13, 2015 - When the results of a test wouldn’t change how doctors manage a patient’s care, most say it’s not worth doing. But new tests for breast cancer risk mutations beyond the well-known BRCA genes would offer actionable information for many women and their doctors, a new study finds.
read article 

Screening for Breast/Ovarian Cancer Risk Genes Other Than BRCA 1/2 Can Change Clinical Recommendations

(Mass General) Aug 13, 2015 - A study by researchers at three academic medical centers has shown that screening women with a suspected risk of hereditary breast or ovarian cancer for risk-associated genes other than BRCA1 and 2 provides information that can change clinical recommendations for patients and their family members.
read press release 

Merck and MD Anderson Announce Immuno-Oncology Research Collaboration in Solid Tumors

(MD Anderson) Aug 13, 2015 - Merck and The University of Texas MD Anderson Cancer Center announced a strategic clinical research collaboration to evaluate Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel anti-tumor medicines.
read press release 

Desperately Seeking Price Reform: The Pharmaceutical Industry Needs To Change Its Ways

(Forbes) Aug 13, 2015 - A familiar trope employed at the climax of movie thrillers is the zombie who returns from the dead to devour the brains of the living.
read article 

GSK Hopes Big Clinical Trial Can Breath New Life Into Lung Drug

(Reuters) Aug 13, 2015 - GlaxoSmithKline is banking on a major clinical trial to revive its flagging respiratory medicine business, with billions of dollars of sales riding on a positive result.
read article 

Roche Buys "Superbug" Diagnostics Firm for Up To $425 Mln

(Reuters) Aug 13, 2015 - Roche is buying U.S. diagnostics firm GeneWEAVE BioSciences for up to $425 million, expanding the Swiss group's commitment to fighting so-called "superbugs" as the threat from drug-resistant microbes grows.
read article 

Kyle Bass Says So What If He Challenges Drug Patents for Profits

(Bloomberg) Aug 12, 2015 - Hedge fund manager Kyle Bass said he challenges drug patents for profit -- but so does everyone else.
read article 

Sandra Lee Is Released From Hospital After Surgery for Infection

(New York Times) Aug 12, 2015 - Sandra Lee, the television host and longtime companion of Gov. Andrew M. Cuomo of New York, was released from the hospital on Wednesday, her spokeswoman said, after undergoing surgery meant to address a lingering infection, several months after she had a double mastectomy for breast cancer.
read article 

Jimmy Carter Says He Has Cancer and It Has Spread

(CNN) Aug 13, 2015 - Former President Jimmy Carter has cancer, and it has spread to other parts of his body, he announced Wednesday.
read article 

Biologics, Inc. Selected to Dispense AstraZeneca's IRESSA® (gefitinib)

(Yahoo! Finance) Aug 13, 2015 - Biologics, Inc. is pleased to announce that it has been selected by AstraZeneca as a specialty pharmacy provider for IRESSA® (gefitinib).
read article 

Myriad Receives Favorable Medicare Final Coverage Decision for the Prolaris(R) Test

(Myriad) Aug 13, 2015 - Myriad Genetics, Inc. today announced that Noridian, the Medicare Administrative Contractor (MAC) for Myriad, has issued a final local coverage determination (LCD) for Prolaris®, Myriad's pioneering prognostic test for assessing the aggressiveness of prostate cancer.
read corporate press release 

BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS® (fentanyl buccal soluble film) CII

(StreetInsider) Aug 13, 2015 - Approval of new formulation expected to allow ONSOLIS to return to U.S. market in 2016.
read article 

FDA Approves U.S. Product Labeling Update for Sprycel® (dasatinib) to Include Five-Year First-Line and Seven-Year Second-Line Efficacy and Safety Data in Chronic Myeloid Leukemia in Chronic Phase

( Aug 13, 2015 - Seven-year study matches the longest duration of follow-up for any CML treatment, including imatinib, based on approved prescribing information.
read article 

ImmunoCellular Therapeutics Reaches Agreement with FDA on Special Protocol Assessment (SPA) for ICT-107 Phase 3 Registrational Trial in Glioblastoma

(StreetInsider) Aug 13, 2015 - ImmunoCellular Therapeutics, Ltd. announced today that it has reached agreement with the US Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the phase 3 registrational trial of its cancer immunotherapy ICT-107 to treat patients with newly diagnosed glioblastoma.
read article 

Ten Ways to Cut Epidemic of Breast Cancer Reoperation

(Medscape Medical News) Aug 12, 2015 - Breast cancer surgeons and care teams can do better in terms of their rate of reoperation after initial lumpectomy, according to a special panel of experts who have created a "toolbox" to reduce the problem of too many follow-up surgeries.
read article (free registration required) 

Landmark Study Validates Method for Patient Reporting of Cancer Drug-Related Adverse Events

(UNC Healthcare) Aug 13, 2015 - In an article published in JAMA Oncology today, a study led by UNC Lineberger's Ethan Basch and colleagues shows that a system they developed accurately and reliably captures the patient experience with cancer drug side effects.
read article 

Can Stem Cells Cause and Cure Cancer?

(Texas A&M HSC/Vital Record) Aug 12, 2015 - Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology believe they may have found one of the reasons why these genes mutate and it all has to do with how stem cells talk to each other.
read article 

Combining Chemotherapy With an Immune-Blocking Drug Could Stop Cancer Growing Back

(Cancer Research [UK]) Aug 13, 2015 - Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people, according to research published in the journal Cancer Research.
read press release 

Solid Subtype Predicts Early Recurrence in Stage I Lung Cancer

(MedPage Today/The Gupta Guide) Aug 12, 2015 - In patients with stage I primary lung adenocarcinoma, solid predominant subtype was an independent predictor of early recurrence and, among those patients who had disease recurrence, it was predictive of worse postrecurrence survival (PRS), according to a 10-year retrospective study.
read article (free registration required) 

Death From Complications After Lung Cancer Surgery

(Medscape Medical News) Aug 12, 2015 - The difference in mortality rates after lung cancer resection between hospitals with high vs low mortality rates appears to be driven primarily by differences between "failure to rescue" rates, or the rates of death due to a complication after surgery, rather than complication rates themselves, a retrospective cohort study suggests.
read article (free registration required) 

UTHealth Research: Older Breast Cancer Patients Less Likely To Benefit From Chemo

(UTHealth) Aug 11, 2015 – Chemotherapy prolongs life for older adults with most types of cancer, but for women over the age of 80 with breast cancer, the chances of survival due to chemotherapy are significantly lower, according to a study led by researchers from The University of Texas Health Science Center at Houston (UTHealth).
read press release 

Transplant Recipients More Likely To Develop Aggressive Melanoma

(Johns Hopkins) Aug 13, 2015 - Organ transplant recipients are twice as likely to develop melanoma as people who do not undergo a transplant, and three times more likely to die of the dangerous skin cancer, suggests new research led by a Johns Hopkins Bloomberg School of Public Health student.
read press release 

FDA Pushes Back Decision on Expanded Use of Bristol-Myers Squibb Drug Opdivo

(NASDAQ/Dow Jones Business News) Aug 12, 2015 - The Food and Drug Administration pushed back the decision date on an expanded use of Bristol-Myers Squibb Co.'s cancer drug Opdivo to Nov. 27, Bristol-Myers said Wednesday.
read article